E4/DRSP FDA Approval Status
Last updated by Judith Stewart, BPharm on June 25, 2020.
FDA Approved: No
Brand name: E4/DRSP
Generic name: estetrol and drospirenone
Company: Mayne Pharma US
Treatment for: Birth Control
E4/DRSP (estetrol and drospirenone) is a novel combined hormonal oral contraceptive pill in development for the prevention of pregnancy.
Development timeline for E4/DRSP
| Date | Article |
|---|---|
| Jun 24, 2020 | Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.